DE69105349T2 - Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung. - Google Patents

Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.

Info

Publication number
DE69105349T2
DE69105349T2 DE69105349T DE69105349T DE69105349T2 DE 69105349 T2 DE69105349 T2 DE 69105349T2 DE 69105349 T DE69105349 T DE 69105349T DE 69105349 T DE69105349 T DE 69105349T DE 69105349 T2 DE69105349 T2 DE 69105349T2
Authority
DE
Germany
Prior art keywords
treatment
synergistic combination
intraocular pressure
ophthalmic use
lowerlakylprostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69105349T
Other languages
English (en)
Other versions
DE69105349D1 (de
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of DE69105349D1 publication Critical patent/DE69105349D1/de
Application granted granted Critical
Publication of DE69105349T2 publication Critical patent/DE69105349T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69105349T 1990-05-22 1991-05-21 Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung. Expired - Lifetime DE69105349T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13290990 1990-05-22

Publications (2)

Publication Number Publication Date
DE69105349D1 DE69105349D1 (de) 1995-01-12
DE69105349T2 true DE69105349T2 (de) 1995-04-06

Family

ID=15092362

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69105349T Expired - Lifetime DE69105349T2 (de) 1990-05-22 1991-05-21 Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.

Country Status (8)

Country Link
US (1) US5208256A (de)
EP (1) EP0458588B1 (de)
JP (1) JPH0798751B2 (de)
AT (1) ATE114470T1 (de)
CA (1) CA2042972C (de)
DE (1) DE69105349T2 (de)
DK (1) DK0458588T3 (de)
ES (1) ES2067864T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364884A (en) * 1993-01-21 1994-11-15 Baylor College Of Medicine Arginine compounds as ocular hypotensive agents
US6770675B2 (en) 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
US6037368A (en) * 1997-05-09 2000-03-14 Mount Sinai School Of Medicine 8-iso- prostaglandins for glaucoma therapy
EP1390035A1 (de) * 2001-05-14 2004-02-25 Sucampo AG Verfahren zur behandlung des erhöhten augeninnendrucks und des glaukoms
CA2458230A1 (en) * 2001-08-23 2003-03-06 Sucampo Ag Method and composition for treatment of ocular hypertension and glaucoma
US20040076678A1 (en) * 2002-08-21 2004-04-22 Sucampo Ag Opthalmic solution
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
US20050119262A1 (en) * 2003-08-21 2005-06-02 Pharmacia Corporation Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
JP4648340B2 (ja) * 2006-02-07 2011-03-09 株式会社アールテック・ウエノ １５−ケトプロスタグランジンｅ誘導体の製造法
EP1985298A1 (de) 2007-04-24 2008-10-29 Azad Pharma AG Prostaglandinhaltige Öl-in-Wasser-Emulsionen für das Auge
US20100087540A1 (en) * 2008-10-07 2010-04-08 R-Tech Ueno, Ltd. Pharmaceutical composition
AU2012243434A1 (en) * 2011-04-12 2013-11-28 Commonwealth Scientific And Industrial Research Organisation Polymer conjugated prostaglandin analogues
US11696955B2 (en) 2017-03-14 2023-07-11 Polyactiva Pty Ltd Drug-polymer conjugate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062964A (en) * 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
JPS52154528A (en) * 1976-05-31 1977-12-22 Kaken Pharmaceut Co Ltd Remedy for glaucoma
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
EP0242580B1 (de) * 1986-03-13 1993-04-28 The Trustees Of Columbia University In The City Of New York Verwendung von A-, B- und C-Prostaglandinen und deren Derivaten zur Behandlung von Augen-Hypertension und Glaukom
US4822819A (en) * 1986-11-07 1989-04-18 Alcon Laboratories, Inc. Use of trimoprostil and derivatives in glaucoma therapy
US4822820A (en) * 1986-11-24 1989-04-18 Alcon Laboratories, Inc. Use of tri-methyl PG-F2 a and derivatives in glaucoma therapy
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
EP0580268B1 (de) * 1988-10-01 1998-01-14 R-Tech Ueno Ltd. Oculare hypotensive Mittel

Also Published As

Publication number Publication date
EP0458588B1 (de) 1994-11-30
EP0458588A1 (de) 1991-11-27
ES2067864T3 (es) 1995-04-01
CA2042972A1 (en) 1991-11-23
DK0458588T3 (da) 1995-03-13
CA2042972C (en) 1996-10-15
JPH04253910A (ja) 1992-09-09
DE69105349D1 (de) 1995-01-12
US5208256A (en) 1993-05-04
JPH0798751B2 (ja) 1995-10-25
ATE114470T1 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
DE69105349T2 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DE69434228D1 (de) Verwendung von Fluprostenolisopropylester zur Herstellung eines Arzneimittels zur Behandlung von Glaukom und okularer Hypertension
ES2059375T3 (es) Utilizacion del tetrahidrocortisol en la terapia del glaucoma.
DE69229944T2 (de) Verwendung von N-Acylaminoalkoholen zur Herstellung eines Arzneimittels zur Behandlung von Mastzellerkrankungen
DE69202019D1 (de) Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS.
DE68918099D1 (de) Pharmazeutische behandlung einer augenentwicklung.
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
ATE107168T1 (de) Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression.
DE69106777D1 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
ATE108658T1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DE69116224T2 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
DE3856052D1 (de) Anwendung des N-n-butyl-Derivates von Desoxynojirimycin zur Herstellung eines Arzneimittels zur Inhibierung von HIV-Virus
DE69100171T2 (de) Synergistische Kombination zur ophthalmischen Verwendung.
DE69032000T2 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69210286T2 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination
EP0069089A3 (en) Intraocular lens
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DE68916777T2 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
SU648187A1 (ru) Состав дл консервировани роговиц человека

Legal Events

Date Code Title Description
8364 No opposition during term of opposition